Northern Discovery Metals agrees to acquire Cibola copper-gold project in British Columbia for CAD 130,000 and 700,000 shares
Bitget2026/10/08 12:04Northern Discovery Metals agreed to acquire a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. Consideration totals CAD 130,000 cash, payable in stages tied to closing and drilling-permit timing. Orogen will retain a 2% net smelter returns royalty, reducible to 1.5% for CAD 5 million under defined study milestones. The property covers about 3,567 hectares, road-accessible, roughly 90 kilometers south-southwest of Houston, British Columbia. Closing remains subject to CSE clearance, with completion expected two business days after conditions are met or waived. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Northern Discovery Metals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080800PRIMZONEFULLFEED9841882) on October 08, 2026, and is solely responsible for the information contained therein.
- Northern Discovery Metals agreed to acquire a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties.
- Consideration totals CAD 130,000 cash, payable in stages tied to closing and drilling-permit timing.
- Orogen will retain a 2% net smelter returns royalty, reducible to 1.5% for CAD 5 million under defined study milestones.
- The property covers about 3,567 hectares, road-accessible, roughly 90 kilometers south-southwest of Houston, British Columbia.
- Closing remains subject to CSE clearance, with completion expected two business days after conditions are met or waived.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
